BIOVIRON is a biotechnology company focusing on the development of innovative viral vectors (herpes simplex virus derived amplicon vectors) for scientific research, industrial processes and therapeutic development. Bioviron works with many entities around the world, including public research centers, biotechnology and pharmaceutical companies in various fields such as drug discovery, vaccines, regenerative medicine, gene and cellular therapies. For instance, BIOVIRON is a participant of the EPIXCHANGE Marie - Curie research program on epilepsy.

Thanks to its proprietary gene transfer technologies based on the amplicon viral vectors, BIOVIRON is the only Biotech company in the world, that conceives, produces and sells amplicon vectors for gene transfer applications. In particular, BIOVIRON has designed new generations of amplicon vectors allowing safe, non-integrative and long lasting gene transfer in nerve cells which are very well adapted for the EPITARGET project.
BIOVIRON’s laboratories are located in the premises of the Center of Cellular and Molecular Genetic and Physiology (CGPhiMC) at the Claude Bernard University of Lyon I (UCBL). BIOVIRON has access to all facilities present in the University, including class 2 laboratories for cell culture, bacterial and viral production, and all material and software for proteins and nucleic acids analysis.

Social Media